Patent Assignment
Reel/Frame 023906/0803
Change of Name
Recorded: 2010-01-26
Pages: 23
Assignor
MERCK & CO., INC.
Executed: 2009-11-02
Assignee
MERCK SHARP & DOHME CORP.
126 EAST LINCOLN AVENUE, RAHWAY, NEW JERSEY, 07065
Covered Properties
(148)
Pyrazole Amide Derivatives, Compositions Containing Such Compounds and Methods of Use
Potassium Channel Inhibitors
Indanone Potentiators of Metabotropic Glutamate Receptors
Application:
11/658,490 →
Publication:
US 2008/0312286
Heterocyclic Acetophenone Potentiators of Metabotropic Glutamate Receptors
Application:
11/658,546 →
Publication:
US 2008/0293684
Vla-4 Antagonists
Pharmaceutical composition containing a cyclooxygenase-2 inhibitor and a proton pump inhibitor
Application:
11/660,195 →
Publication:
US 2008/0096927
Histone Deacetylase Inhibitors
Monocyclic Anilide Spirolactam Cgrp Receptor Antagonists
Ophthalmic Compositions for Treating Ocular Hypertension
Application:
11/660,838 →
Publication:
US 2007/0293558
Antibiotic Compound
Application:
11/661,466 →
Publication:
US 2008/0096856
Ophthalmic Compositions for Treating Ocular Hypertension
Application:
11/661,649 →
Publication:
US 2008/0097108
Acyclic Hydrazides as Cannabinoid Receptor Modulators
Application:
11/661,834 →
Publication:
US 2008/0076805
Aminopiperidines as Dipeptidyl Peptidase-Iv Inhibitors for the Treatment or Prevention of Diabetes
Compositions and Methods for Treating Ophthalmic Diseases
Application:
11/662,110 →
Publication:
US 2008/0096859
Tricyclic Anilide Spirolactam Cgrp Receptor Antagonists
A Method of Treating Cancer
Application:
11/662,396 →
Publication:
US 2009/0012061
Aryl Spirolactam Cgrp Receptor Antagonists
Tricyclic Anilide Spirohydantion Cgrp Receptor Antagonists
Bicyclic Anilide Spirolactam Cgrp Receptor Antagonists
Polypeptides for Inducing a Protective Immune Response Against Staphylococcus Aureus
Application:
11/663,037 →
Publication:
US 2007/0264278
Polypeptides For Inducing A Protective Immune Response Against Staphylococcus Aureus
Application:
11/663,112 →
Publication:
US 2008/0095792
Formulations of Suberoylanilide Hydroxamic Acid and Methods for Producing Same
Cyclopropyl Piperidine Glycine Transporter Inhibitors
Thiazolyl MGLUR5 Antagonists and Methods for Their Use
Nucleoside Derivatives as Inhibitors of Rna-Dependent Rna Viral Polymerase
N-(2-Benzyl)-2-Phenylbutanamides as Androgen Receptor Modulators
Assays using amyloid precursor proteins with modified beta-secretase cleavage sites to monitor beta-secretase activity
Application:
11/714,985 →
Publication:
US 2007/0219354
Aminotetrahydropyrans as Dipeptidyl Peptidase-Iv Inhibitors for the Treatment or Prevention of Diabetes
Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment
Application:
11/791,183 →
Publication:
US 2007/0281969
Bicyclic Pyrimidines as Dipeptidyl Peptidase-Iv Inhibitors for the Treatment or Prevention of Diabetes
Antidiabetic Bicyclic Compounds
Application:
11/794,591 →
Publication:
US 2008/0090865
Antidiabetic Bicyclic Compounds
Inhibitors of Checkpoint Kinases
Application:
11/795,005 →
Publication:
US 2008/0280902
Tertiary Carbinamines Having Substituted Heterocycles Which Are Active as Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
Aminomethyl Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
Mitotic Kinesin Inhibitors
Mitotic Kinesin Inhibitors
Application:
11/795,440 →
Publication:
US 2008/0102068
Mitotic Kinesin Inhibitors
Application:
11/795,448 →
Publication:
US 2009/0124641
Method of Treating Atherosclerosis, Dyslipidemias and Related Conditions
Application:
11/795,484 →
Publication:
US 2008/0139604
Polypeptides for Inducing a Protective Immune Response Against Staphylococcus Aureus
Cgrp Receptor Antagonists
Purification Process for Plasmid Dna
Tyrosine Kinase Inhibitors
High Affinity Antibody Antagonists of Interleukin-13 Receptor Alpha 1
Substituted Pyrazoles as Modulators of Chemokine Receptors
Application:
11/884,325 →
Publication:
US 2008/0167322
Benzazole Potentiators of Metabotropic Glutatmate Receptors
Fused-Aromatic Compounds Having Anti-Diabetic Activity
Process for the Preparation of (R)-4,4-Dialkoxy-Pyran-3-Ols Such as (R)-4,4-Dimethoxy-Pyran-3-Ol
Application:
11/885,309 →
Publication:
US 2008/0138866
Composition for Inhibition of Cathepsin K
Novel Crystalline Forms of Antidiabetic Compounds
Diphenyl Substituted Cycloalkanes, Compositions Containing Such Compounds and Methods Of Use
Application:
11/885,851 →
Publication:
US 2009/0197883
Cgrp Receptor Antagonists
Quinazolinone T-Type Calcium Channel Antagonists
Substituted Aryl and Heteroaryl Derivatives, Compositions Containing Such Compounds and Methods of Use
Hcv Protease Substrates
Mitotic Kinesin Inhibitors
Application:
11/886,282 →
Publication:
US 2008/0207693
Angiotensin Ii Receptor Antagonists
Application:
11/886,553 →
Publication:
US 2009/0123538
Method of treating men with testosterone supplement and 5alpha-reductase inhibitor
Application:
11/887,012 →
Publication:
US 2009/0123571
Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds and Methods of Use
Human Niemann Pick C1-Like 1 Gene (NPC1L1) Polymorphisms and Methods of Use Thereof
Application:
11/887,346 →
Publication:
US 2009/0192135
Amidopropoxyphenyl Orexin Receptor Antagonists
Application:
11/887,666 →
Publication:
US 2008/0262046
VLA-4 Antagonists
Application:
11/887,701 →
Publication:
US 2009/0069376
Tyrosine kinase inhibitors
Application:
11/890,755 →
Publication:
US 2008/0008708
Human calcium sensitive potassium channel beta3 subunit proteins, encoding nucleic acid and uses thereof
Application:
11/903,092 →
Publication:
US 2009/0117590
VLA-4 Antagonists
Application:
11/918,100 →
Publication:
US 2009/0048308
Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment
Application:
11/918,270 →
Publication:
US 2009/0054423
Inhibitors of Akt Activity
Benzothiophene Hydroxamic Acid Derivatives with Carbamate, Urea, Amide and Sulfonamide Substitutions
Benzothiophene Hydroxamic Acid Derivatives
Benzothiophene Derivatives
Phenyl ethyne compounds
Application:
11/918,993 →
Publication:
US 2009/0306115
D-Homoandrosta-17-Yl Carbamate Derivatives as Selective Glucocorticoid Receptor Ligands
Combination of a Dipeptidyl Peptidase-IV Inhibitor and a Cannabinoid CB1 Receptor Antagonist for the Treatment of Diabetes and Obesity
Application:
11/919,308 →
Publication:
US 2009/0306037
Tyrosine kinase inhibitors
Application:
11/919,758 →
Publication:
US 2009/0156617
Peptide Conjugate Compositions and Methods for the Prevention and Treatment of Alzheimer's Disease
Hiv Integrase Inhibitors
Aminocyclohexanes as Dipeptidyl Peptidase-Iv Inhibitors for the Treatment of Diabetes
Hydroisoindoline Tachykinin Receptor Antagonists
Quinolone M1 Receptor Positive Allosteric Modulators
Benzocycloheptapyridines as Inhibitors of the Receptor Tyrosine Kinase Met
Inhibitors of Akt Activtiy
Inhibitors of checkpoint kinases
Application:
11/921,598 →
Publication:
US 2009/0233896
Crystalline Forms of MC4R Agonist and Process for Synthesis
Synthetic Gene Control Region
Anti-Hypercholesterolemic Compounds
Method for Identifying Modulators of KEAH6 Useful for Treating Alzheimer's Disease
Application:
11/922,152 →
Publication:
US 2009/0047702
Targets for Inhibiting Hcv Replication
Application:
11/922,188 →
3-Fluoro-Piperidine T-Type Calcium Channel Antagonists
Application:
11/922,390 →
Publication:
US 2010/0222387
4-Fluoro-Piperidine T-Type Calcium Channel Antagonists
Process for Making Hydroisoindoline Tachykinin Receptor Antagonists
Application:
11/922,446 →
Publication:
US 2010/0036135
Method for Producing 4(3H)-Quinazolinone Derivative
Application:
11/922,479 →
Publication:
US 2009/0131664
Method for Identiflying Modulators of Rufy2 Useful for Treating Alzheimer's Disease
Application:
11/922,527 →
Publication:
US 2010/0041026
Composition and Method for a Producing Stable Amyloid Beta Oligomers of High Molecular Weight
Application:
11/922,528 →
Publication:
US 2010/0240868
Method for Preparing a Covalently Cross Linked Oligomer of Amyloid Beta Peptides
Application:
11/922,552 →
Publication:
US 2010/0143396
Antidiabetic Oxazolidinediones and Thiazolidinediones
Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment
Non-Nucleoside Reverse Transcriptase Inhibitors
Application:
11/922,672 →
Publication:
US 2010/0168097
Non-Nucleoside Reverse Transcriptase Inhibitors
Application:
11/922,681 →
Publication:
US 2010/0179122
Non-Nucleoside Reverse Transcriptase Inhibitors
Application:
11/922,682 →
Publication:
US 2010/0222322
Modified Malonate Derivatives
Process for Synthesizing a Cetp Inhibitor
Dodecylsulfate Salt Of A Dipeptidyl Peptidase-Iv Inhibitor
Application:
11/988,197 →
Publication:
US 2009/0221592
Potassium Channel Inhibitors
Inhibitors of Checkpoint Kinases
Application:
11/988,394 →
Publication:
US 2009/0258852
Spirochromanone Derivatives as Acetyl Coenzyme a Carboxylase (Acc) Inhibitors
Synthesis and Crystalline Forms of NPY5 Antagonist
Antidiabetic Oxazolidinediones and Thiazolidinediones
Application:
11/988,791 →
Publication:
US 2009/0069385
Process for Synthesizing a Substituted Pyrazole
Heterocyclic Benzodiazepine Cgrp Receptor Antagonists
Inhibitors of checkpoint kinases
Application:
11/989,266 →
Publication:
US 2009/0182001
N-(Pyridin-4-Yl)-2-Phenylbutanamides as Androgen Receptor Modulators
Application:
11/989,412 →
Publication:
US 2009/0088458
Aminoethane Sulfonamide Orexin Receptor Antagonists
Application:
11/989,847 →
Publication:
US 2009/0258903
Hcv NS3 Protease Inhibitors
Tricyclic Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
Application:
11/989,919 →
Publication:
US 2009/0170830
Tricyclic Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
Application:
11/989,989 →
Publication:
US 2009/0182021
Cyclic Ketal Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
Fused Aminopiperidines as Dipeptidyl Peptidase-Iv Inhibitors for the Treatment or Prevention of Diabetes
P38 Kinase Inhibiting Agents
Acetal Derivatives for the Treatment of Rna-Dependent Rna-Viral Infection
Non-Nucleoside Reverse Transcriptase Inhibitors
Application:
11/990,060 →
Publication:
US 2009/0131494
Dna Repair Pathway Targets in Hiv
Application:
11/990,174 →
Publication:
US 2009/0221679
Novel 2'-C-Methyl and 4'-C-Methylnucleoside Derivatives
Application:
11/990,379 →
Publication:
US 2009/0118223
Diazaspirodecane orexin receptor antagonists
Application:
11/990,585 →
Publication:
US 2009/0176789
Combination methods fo saha and targretin for treating cancer
Application:
11/990,724 →
Publication:
US 2009/0227674
Niacin receptor agonists, compositions containing such compounds and methods of treatment
Application:
11/991,188 →
Publication:
US 2009/0258862
Radiolabeled Glycine Trasporter Inhibitors
Tyrosine Kinase Inhibitors
Application:
11/991,862 →
Publication:
US 2009/0149467
Acylated Spiropiperidine Derivatives as Melanocortin-4 Receptor Modulators
Acylated Piperidine Derivatives as Melanocortin-4 Receptor Agonists
Application:
11/992,343 →
Publication:
US 2010/0160306
N-(4-Oxo-3,4-Dihydroquinazolin-2Yl) Butanamides as Androgen Receptor Modulators
Application:
11/992,446 →
Publication:
US 2010/0267633
Nucleic Acids Encoding a Functional Mammalin Purinoreceptor, P2X3, Methods of Production and Use Thereof
Application:
11/992,634 →
Publication:
US 2010/0221773
Cholesteryl Ester Transfer Protein Inhibitors
Application:
11/992,816 →
Publication:
US 2010/0167986
Estrogen Receptor Modulators
Anti-Hypercholesterolemic Compounds
Application:
11/992,990 →
Publication:
US 2009/0137546
Substituted Diazepan Orexin Receptor Antagonists
Non-Nucleoside Reverse Transcriptase Inhibitors
Angiotensin Ii Receptor Antagonists
Substituted Spirochromanone Derivatives
Androgen receptor modulators and methods of use thereof
Application:
12/009,113 →
Publication:
US 2008/0119503
Substituted Pyrano[2,3-B]Pyridine Derivatives as Cannabinoid-1 Receptor Modulators
Antibodies Specific for Dkk-1
Papillomavirus Vaccine Compositions
Substituted furo[2,3-B] pyridine derivatives as cannabinoid-1 receptor modulators
Application:
12/082,013 →
Publication:
US 2008/0269279
Triazole Derivatives Which Are Smo Antagonists
Combination Therapy for the Treatment of Urinary Frequency, Urinary Urgency and Urinary Incontinence
Triazole Derivatives as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase-1
Production of Glycoproteins with Reduced O-Glycosylation
Crystalline forms of an HIV integrase inhibitor
Application:
12/151,744 →
Publication:
US 2008/0280945
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name
Dec 17, 2009
From: MERCK & CO., INC.
To: MERCK SHARP & DOHME CORP.
Reel/Frame 023669/0726 →
Merger
Aug 27, 2012
From: MERCK SHARP & DOHME CORP.
To: SCHERING CORPORATION
Reel/Frame 028850/0515 →
Change of Name
Aug 29, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028866/0511 →
Merger
Aug 8, 2022
From: MERCK SHARP & DOHME CORP.
To: MERCK SHARP & DOHME LLC
Reel/Frame 061102/0145 →